title: Serum deprivation inhibits glutathione depletion-induced death in embryonic cortical neurons: evidence against oxidative stress as a final common mediator of neuronal apoptosis.
abstract: We have previously shown that glutamate-induced cystine deprivation of embryonic cortical neurons leads to intracellular depletion of the antioxidant glutathione, consequent oxidative stress and apoptotic cell death. To test the hypothesis that glutathione depletion and oxidative stress represent a common pathway of neuronal apoptosis, we examined the effect of a variety of antioxidants on serum deprivation-induced death in embryonic cortical neurons. A host of antioxidant agents, capable of abrogating glutathione depletion-induced apoptosis in cortical neurons, were unable to inhibit serum deprivation-induced death in these cells. To test whether serum deprivation and glutathione depletion involve different or antagonistic pathways, we serum-deprived cortical neurons at the time of induction of glutathione depletion. Surprisingly, we found that serum deprivation diminished glutathione depletion-induced death as compared to cultures treated with growth factors or serum. These observations suggest that serum deprivation antagonizes the cell death signaling pathway activated by glutathione depletion and that serum and growth factors can enhance susceptibility to oxidative stress. Consistent with these conclusions, we show that growth factors or serum added in combination with antioxidants possess superior survival promoting effects as compared to either agent alone.
authors.affiliation: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
authors.forename: R R
authors.initials: RR
authors.lastname: Ratan
authors.forename: P J
authors.initials: PJ
authors.lastname: Lee
authors.forename: J M
authors.initials: JM
authors.lastname: Baraban
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D017209:Apoptosis; D019208:Brain-Derived Neurotrophic Factor / Q000494:pharmacology; D002083:Butylated Hydroxyanisole / Q000494:pharmacology; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology* / Q000196:embryology*; D016895:Culture Media, Serum-Free; D003553:Cystine / Q000494:pharmacology; D003676:Deferoxamine / Q000494:pharmacology; D005978:Glutathione / Q000008:administration & dosage*; D007328:Insulin / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D018384:Oxidative Stress; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000975:Antioxidants; D019208:Brain-Derived Neurotrophic Factor; D016895:Culture Media, Serum-Free; D007328:Insulin; D002083:Butylated Hydroxyanisole; D003553:Cystine; D005978:Glutathione; D003676:Deferoxamine; D000111:Acetylcysteine